Dicentric chromosomes and 20q11.2 amplification in MDS/AML with apparent monosomy 20

Cytogenetic and Genome Research

Volumn 119, Issue 3-4, 2007, Pages 211-220

  MacKinnon, R N ^a,b   Campbell, L J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CENTROMERE; CHROMOSOME 20; CHROMOSOME 21; CLINICAL ARTICLE; CONTROLLED STUDY; DICENTRIC CHROMOSOME; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE DELETION; GENE IDENTIFICATION; GENE STRUCTURE; GENE TRANSLOCATION; HUMAN; KARYOTYPE; MONOSOMY; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

CENTROMERE; CHROMOSOME ABERRATIONS; CHROMOSOME BANDING; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 20; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MONOSOMY; MYELODYSPLASTIC SYNDROMES; POLYPLOIDY;

EID: 39049158728     PISSN: 14248581     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112063     Document Type: Article

References (36)

1. Andersen MK, Pedersen-Bjergaard J: Increased frequency of dicentric chromosomes in therapy-related MDS and AML compared to de novo disease is significantly related to previous treatment with alkylating agents and suggests a specific susceptibility to chromosome breakage at the centromere. Leukemia 14:105-111 (2000).
2. Bench AJ, Nacheva EP, Hood TL, Holden JL, French L, et al: Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG). Oncogene 19:3902-3913 (2000).
3. Bench AJ, Li J, Huntly BJ, Delabesse E, Fourouclas N, et al: Characterization of the imprinted polycomb gene L3MBTL , a candidate 20q tumour suppressor gene, in patients with myeloid malignancies. Br J Haematol 127:509-518 (2004).
4. Berger R, Busson-Le Coniat M: Centric and pericentric chromosome rearrangements in hematopoietic malignancies. Leukemia 13:671-678 (1999).
5. Bram S, Swolin B, Rodjer S, Stockelberg D, Ogard I, Back H: Is monosomy 5 an uncommon aberration? Fluorescence in situ hybridization reveals translocations and deletions in myelodysplastic syndromes or acute myelocytic leukemia. Cancer Genet Cytogenet 142:107-114 (2003).
6. Bram S, Rodjer S, Swolin B: Several chromosomes involved in translocations with chromosome 5 shown with fluorescence in situ hybridization in patients with malignant myeloid disorders. Cancer Genet Cytogenet 155:74-78 (2004).
7. Campbell LJ, Garson OM: The prognostic significance of deletion of the long arm of chromosome 20 in myeloid disorders. Leukemia 8:67-71 (1994).
8. Chudoba I, Hickmann G, Friedrich T, Jauch A, Kozlowski P, Senger G: mBAND: a high resolution multicolor banding technique for the detection of complex intrachromosomal aberrations. Cytogenet Genome Res 104:390-393 (2004).
9. Falzetti D, Vermeesch JR, Hood TL, Nacheva EP, Matteucci C, et al: Identification of multiple copies of a 20q-chromosome in a case of myelodysplastic syndrome: a FISH study. Leuk Res 2:407-413 (1999).
10. Fujita Y, Sakakura C, Shimomura K, Nakanishi M, Yasuoka R, et al: Chromosome arm 20q gains and other genomic alterations in esophageal squamous cell carcinoma, as analyzed by comparative genomic hybridization and fluorescence in situ hybridization. Hepatogastroenterology 5:1857-1863 (2003).
11. Guan XY, Xu J, Anzick SL, Zhang H, Trent JM, Meltzer PS: Hybrid selection of transcribed sequences from microdissected DNA: isolation of genes within amplified region at 20q11-q13.2 in breast cancer. Cancer Res 56:3446-3450 (1996).
12. Herry A, Douet-Guilbert N, Morel F, Le Bris M-J, De Braekeleer M: Redefining monosomy 5 by molecular cytogenetics in 23 patients with MDS/AML. Eur J Haematol 78:457-467 (2007).
13. ISCN (2005): An International System for Human Cytogenetic Nomenclature (2005), Shaffer LG, Tommerup NS (eds) (S. Karger, Basel 2005).
14. Jaffe ES, Harris NL, Stein H, Vardiman JW: World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (IARC Press, Lyon, 2001).
15. Johansson B, Mertens F, Mitelman F: Cytogenetic deletion maps of hematologic neoplasms: circumstantial evidence for tumor suppressor loci. Genes Chromosomes Cancer 8:205-218 (1993).
16. Li J, Bench AJ, Vassiliou GS, Fourouclas N, Ferguson-Smith AC, Green AR.: Imprinting of the human L3MBTL gene, a polycomb family member located in a region of chromosome 20 deleted in human myeloid malignancies. Proc Natl Acad Sci USA 101:7341-7346 (2004a).
17. Li T, Xue Y, Wu Y, Pan J: Clinical and molecular cytogenetic studies in seven patients with myeloid diseases characterized by i(20q-). Br J Haematol 125:337-342 (2004b).
18. MacGrogan D, Kalakonda N, Alvarez S, Scandura JM, Boccuni P, et al: Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells. Genes Chromosomes Cancer 41:203-213 (2004).
19. MacKinnon RN, Campbell LJ: A comparison of two contrasting recurrent isochromosomes 20 found in myelodysplastic syndromes suggests that retention of proximal 20q is a significant factor in myeloid malignancies. Cancer Genet Cytogenet 163:176-179 (2005).
20. MacKinnon RN, Patsouris C, Chudoba I, Campbell LJ: A FISH comparison of variant derivatives of the recurrent dic(17; 20) of myelodysplastic syndromes and acute myeloid leukemia: Obligatory retention of genes on 17p and 20q may explain the formation of dicentric chromosomes. Genes Chromosomes Cancer 46:27-36 (2007).
21. Martinez-Ramirez A, Urioste M, Alvarez S, Vizmanos JL, Calasanz MJ, et al: Cytogenetic profile of myelodysplastic syndromes with complex karyotypes: an analysis using spectral karyotyping. Cancer Genet Cytogenet 153:39-47 (2004).
22. Martinez-Ramirez A, Urioste M, Melchor L, Blesa D, Valle L, et al: Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array. Genes Chromosomes Cancer 42:287-298 (2005).
23. Mitelman F, Johansson B, Mertens FE: Mitelman Database of Chromosome Aberrations in Cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman (2007).
24. Mrozek K, Heinonen K, Theil KS, Bloomfield CD: Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent over-representation of 21q, 11q, and 22q. Genes Chromosomes Cancer 34:137-153 (2002).
25. Ohyashiki K, Murakami T, Ohyashiki JH, Kodama A, Sakai N, et al: Double 20q- anomaly in myelodysplastic syndrome. Cancer Genet Cytogenet 58:174-176 (1992).
26. Page SL, Shaffer LG: Chromosome stability is maintained by short intercentromeric distance in functionally dicentric human Robertsonian translocations. Chromosome Res 6:115-122 (1998).
27. Patsouris C, Michael PM, Campbell LJ: A new nonrandom unbalanced t(17; 20) in myeloid malignancies. Cancer Genet Cytogenet 138:32-37 (2002).
28. Pinkel D, Landegent J, Collins C, Fuscoe J, Segraves R, et al: Fluorescence in situ hybridization with human chromosome-specific libraries: detection of trisomy 21 and translocations of chromosome 4. Proc Natl Acad Sci USA 85:9138-9142 (1988).
29. Rucker FG, Bullinger L, Schwaenen C, Lipka DB, Wessendorf S, et al: Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization. J Clin Oncol 24:3887-3894 (2006).
30. Sait SN, Qadir MU, Conroy JM, Matsui S, Nowak NJ, Baer MR: Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome: identification of new amplification regions by fluorescence in situ hybridization and spectral karyotyping. Genes Chromosomes Cancer 34:42-47 (2002).
31. Smith LT, Mayerson J, Nowak NJ, Suster D, Mohammed N, et al: 20q11.1 amplification in giant-cell tumor of bone: Array CGH, FISH, and association with outcome. Genes Chromosomes Cancer 45:957-966 (2006).
32. Speicher MR, Gwyn Ballard S, Ward DC: Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet 12:368-375 (1996).
33. Sullivan BA, Willard HF: Stable dicentric X chromosomes with two functional centromeres. Nat Genet 20:227-228 (1998).
34. Trost D, Hildebrandt B, Beier M, Muller N, Germing U, Royer-Pokora B: Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia. Cancer Genet Cytogenet 165:51-63 (2006).
35. Wang P, Spielberger RT, Thangavelu M, Zhao N, Davis EM, et al: dic(5; 17): a recurring abnormality in malignant myeloid disorders associated with mutations of TP53 . Genes Chromosomes Cancer 20:282-291 (1997).
36. Wilting S, Snijders P, Meijer G, Ylstra B, van den Ijssel P, et al: Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix. J Pathol 209:220-230 (2006).